DEBIOINVESTMENT
DEBIOINVESTMENT
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2013-09-17 | SmallRivers | Debioinvestment investment in Venture Round - SmallRivers | 2 M USD |
More informations about "Debioinvestment"
Debioinvestment - Investments, Portfolio & Company Exits
Sep 17, 2013 Debioinvestment has invested in SmallRivers on Sep 17, 2013. This investment - Venture Round - SmallRivers - was valued at . obfuscated. obfuscated. Debioinvestment has …See details»
Debioinvestment Investor Profile: Portfolio & Exits - PitchBook
Debioinvestment's latest investment was on 17-Sep-2013 in Finity (Media and Information Services), a company within the Media and Information Services (B2B) industry. Data …See details»
Debioinvestment Portfolio Exits - CB Insights
Posted Amazon’s Instant Video App Adds AirPlay Support For Streaming To Apple TV Smallrivers , the Swiss startup behind news curation platform Paper.li , has raised further funding: $2 …See details»
Debioinvestment - Crunchbase
Debioinvestment was added in 2013.See details»
Debioinvestment — 1 Investments, Performance analytics, Stats — …
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Debioinvestment, startups are often financed by VI Partners AG, SoftBank Capital, Kima …See details»
Debiopharm - Wikipedia
Debiopharm is the Life Science division of the holding company Après-demain (litt. "The Day after Tomorrow") with three subsidiaries active in drug development (Debiopharm International), …See details»
Startup funding - Debiopharm
We grant our start-ups access to Debiopharm’s wealth of expertise by facilitating connections between start-ups and our internal experts. This enables startups to test their hypotheses and …See details»
M E D I A F A C T S H E E T - Debiopharm
4. Debiopharm – Oncology and Antibiotic Pipeline With patients in mind and to continue providing treatments, Debiopharm has 18 projects in development in its pipeline in its specialty areas …See details»
Acquisition of Debiopharm's Investment Portfolio Company Kaiku …
LAUSANNE, Switzerland, May 26, 2020 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the successful exit and acquisition of …See details»
Debiopharm Innovation Fund - Debiopharm
You’ve ignited your Health Tech idea, now, fuel it further. While financing is key, expert advice and deepened market knowledge provide a priceless competitive advantage.See details»
Debio - Investments, Portfolio & Company Exits - Crunchbase
Which industries has this organization most actively invested in? Show . Announced Date . Organization Name . Lead Investor . Funding Round . Money Raised . Aug 31, 2021:See details»
Debiopharm Co-leads a 10M USD Series A Round to Accelerate …
Sep 13, 2022 Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer …See details»
Debiopharm International SA – Swiss Biotech
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial …See details»
Debiopharm Innovation Fund: a new seed fund dedicated to …
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Debiopharm Innovation Fund - Crunchbase Investor Profile
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs …See details»
Debiopharm - We develop for patients and their quality of life
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial …See details»
Community Bonds that turned Waste into Power - Tapestry Capital
Jul 8, 2021 To date, the organization has raised over $7 million from over 700 investors, to invest in the project and to refinance earlier investments that are now maturing. The co-op also …See details»
Major investments in domestic firms to rebuild Canada's ...
Mar 16, 2021 As a CDMO—a contract development and manufacturing organization—our investment will provide valuable services to support Canadian and foreign biopharmaceutical …See details»
Debiopharm Group - Crunchbase Company Profile & Funding
Debiopharm Group may be growing as it has provided additional funding to MedaSystems, which indicates an increase in investment activities. This financial support is aimed at accelerating …See details»